Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants. | ClinicLens
Although the beneficial effects of sodium-glucose cotransporter 2 (SGLT2) inhibition in heart failure (HF) have been well established, it is unknown whether SGLT2 inhibition confers benefit in carriers of rare variants in cardiomyopathy-associated genes. Here we evaluated whole-e
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.